Preprint identifies distal regulatory variant on GBA1 haplotype as potential driver of Parkinson's neuroinflammation
A bioRxiv preprint integrating whole-genome sequencing, transcriptomic, and epigenomic data proposes that an overlooked non-coding regulatory signal may help explain why GBA1 coding variants substantially raise Parkinson's disease risk.
A preprint deposited on bioRxiv reports that researchers using the Parkinson's Progression Markers Initiative (PPMI) resource have identified what they describe as a previously overlooked distal regulatory signal sitting on a shared haplotype with GBA1 coding variants. GBA1 coding variants are well established as the strongest common genetic risk factor for Parkinson's disease (PD), yet how they confer polygenic PD risk when the same variants cause Gaucher disease through a distinct monogenic mechanism has remained unresolved.
The team integrated whole-genome sequencing from sporadic PD cases and controls with matched transcriptomic, epigenomic, and cerebrospinal fluid proteomic data across Northern European and Ashkenazi Jewish populations. Ancestry-specific genetic maps were used to localise disease signals. The authors propose that the distal regulatory element drives a neuroinflammatory cascade, rather than acting solely through the well-characterised lysosomal glucocerebrosidase pathway encoded by GBA1 itself.
The work has not yet been peer-reviewed. The findings are primarily of interest to researchers studying the genetic architecture of Parkinson's disease, lysosomal biology, and neuroinflammation. Genetic counsellors working with families affected by GBA1-related conditions may also note the evolving understanding of how this locus operates in different disease contexts.
As a preprint, these results should be considered preliminary until independent replication and peer review.
Plain-language version
For patients, families, and general readers. Educational only — not medical advice.
The GBA1 gene is the most important common genetic risk factor for Parkinson's disease. Certain changes in GBA1 are also responsible for a rare storage disorder called Gaucher disease. Scientists have long been puzzled by how the same gene can be involved in two such different conditions.
A new research report — not yet checked by independent expert reviewers — suggests that a stretch of DNA near the GBA1 gene, which controls how it is switched on and off, may play an important role. The researchers analysed genetic, brain tissue, and spinal fluid data from hundreds of Parkinson's patients and healthy volunteers. They propose this overlooked regulatory region triggers inflammation in the brain, which could help explain the Parkinson's risk.
This is early-stage research and has not yet been through formal peer review. It does not change current clinical guidance for people with GBA1 variants or their families.
This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary sourcePreprint bioRxiv (Cold Spring Harbor Laboratory) · 2026-07-13An overlooked distal regulatory signal on a shared haplotype drives the neuroinflammatory cascade underlying GBA1-associated Parkinson's disease